Protagonist Therapeutics, Inc.
Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases

Abstract:

The present invention provides novel peptide inhibitors of the interleukin-23 receptor, and related compositions and methods of using these peptide inhibitors to treat or prevent a variety of diseases and disorders, including inflammatory bowel diseases.